New shot aims to tame hepatitis b in early trial
Disease control
Completed
This study tests a new drug, AHB-137, given as a shot under the skin. It first checks safety in healthy volunteers, then tests how well it works in people with chronic hepatitis B who are already on standard antiviral pills. The goal is to see if AHB-137 can lower or clear the he…
Phase: PHASE1, PHASE2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC